| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/07/1997 | WO1997028153A1 Chinoline and benzimidazole derivatives as bradykinin agonists |
| 08/07/1997 | WO1997028148A1 Dihydrobenzofuran compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028146A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028144A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028143A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028128A1 Heterocyclic compounds useful as pharmaceutical agents |
| 08/07/1997 | WO1997028125A1 Dihydropyridine derivatives and medicinal compositions containing the same |
| 08/07/1997 | WO1997028121A1 Alkylated styrenes as prodrugs to cox-2 inhibitors |
| 08/07/1997 | WO1997028120A1 Diphenyl stilbenes as prodrugs to cox-2 inhibitors |
| 08/07/1997 | WO1997027867A1 Protection of hemopoietic cells |
| 08/07/1997 | WO1997027863A1 Combined pharmaceutical preparation containing lhrh-analogous substances and anti-estrogens for treating gynaecological disorders |
| 08/07/1997 | WO1997027854A1 Inhibitors of farnesyl-protein transferase |
| 08/07/1997 | WO1997027853A1 Inhibitors of farnesyl-protein transferase |
| 08/07/1997 | WO1997027852A1 Inhibitors of farnesyl-protein transferase |
| 08/07/1997 | WO1997027848A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS |
| 08/07/1997 | DE19703816A1 Additives for injection or infusion solutions, especially of contrast agents |
| 08/07/1997 | DE19604919A1 Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel New 2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 08/07/1997 | CA2630098A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | CA2245165A1 Sensitization of her2/neu over-expressing cancer cells to chemotherapeutic drugs |
| 08/07/1997 | CA2245145A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 08/07/1997 | CA2245085A1 Protection of hemopoietic cells |
| 08/07/1997 | CA2244755A1 Mhc complexes and uses thereof |
| 08/07/1997 | CA2244673A1 Peptide inhibitors of hematopoietic cell proliferation |
| 08/07/1997 | CA2244411A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/06/1997 | EP0787797A1 Human 5-HT1D receptor (serotonin receptor), process for preparing the same, its uses, antibodies directed against this receptor and transgenics expressing it |
| 08/06/1997 | EP0787739A1 Anti-adhesive piperidine and pyrollidine -carboxylic acids |
| 08/06/1997 | EP0787733A2 Novel bioactive substance K93-0711 I-1 and I-2, and process for production thereof |
| 08/06/1997 | EP0787723A1 Cyclopropachromenecarboxylate derivatives |
| 08/06/1997 | EP0787722A1 Substituted quinazoline derivatives |
| 08/06/1997 | EP0787717A1 Substituted diaryl dicarboxylic acid diguanidines, process for their preparation, their use as inhibitors of the Na+/H+ exchange as well as medicament or diagnostic agent containing them |
| 08/06/1997 | EP0787499A1 Kininogen for promoting bone formation and inhibiting bone resorption |
| 08/06/1997 | EP0787492A1 Use of nitroxides and oxazolidines for protection against ionising radiation and oxidative stress |
| 08/06/1997 | EP0787148A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/06/1997 | EP0787143A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 08/06/1997 | EP0787135A1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer |
| 08/06/1997 | EP0787133A1 Tricyclic spiro compounds process for their preparation and their use as 5ht1d receptor antagonists |
| 08/06/1997 | EP0787132A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments |
| 08/06/1997 | EP0787131A1 Benzenesulphonamide derivatives as bradykinine antagonists |
| 08/06/1997 | EP0787127A1 5-lipoxygenase inhibitors |
| 08/06/1997 | EP0787123A1 Inhibitors of farnesyl-protein transferase |
| 08/06/1997 | EP0787016A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 08/06/1997 | EP0787010A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes |
| 08/06/1997 | EP0787001A1 Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis |
| 08/06/1997 | EP0787000A1 Quinazolinone pharmaceuticals and use thereof |
| 08/06/1997 | EP0786999A1 Combination method for acne treatment |
| 08/06/1997 | EP0786997A1 Muscarine antagonists |
| 08/06/1997 | EP0786996A1 Cysteine protease and serine protease inhibitors |
| 08/06/1997 | EP0786992A2 Lta 4? hydrolase inhibitor pharmaceutical compositions and methods of use |
| 08/06/1997 | EP0786991A1 Polyamine compounds for treating vascular proliferative disorders |
| 08/06/1997 | EP0786988A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs |
| 08/06/1997 | EP0786946A1 Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed |
| 08/06/1997 | EP0585397B1 Bombesin analogs |
| 08/06/1997 | EP0540757B1 Water-based recording ink |
| 08/06/1997 | EP0479799B1 Wound healing |
| 08/06/1997 | CN1156454A N-substituted 3-azabicyclo(3,2,0) heptane derivatives and preparing method and use thereof |
| 08/06/1997 | CN1156451A Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 08/06/1997 | CN1156449A Dihygropyridine derivatives as bradykinin antagonists |
| 08/06/1997 | CN1156447A 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 08/06/1997 | CN1156410A Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
| 08/06/1997 | CN1156406A Methods for inhibiting bone prosthesis degeneration |
| 08/05/1997 | US5654445 Intermediates for renin inhibitors, hypotensive agents |
| 08/05/1997 | US5654436 Inhibitors of smooth muscle cell proliferation |
| 08/05/1997 | US5654427 Protein kinase inhibitors |
| 08/05/1997 | US5654407 Human anti-TNF antibodies |
| 08/05/1997 | US5654405 Detection and purification of kgf; treating excessive epithelial cell growth; skin disorders, e.g., psoriasis; antitumor and carcinogenic agents |
| 08/05/1997 | US5654328 Synergistic mixture of platinum compound with tellurium or selenium compound as antitumor or anticarcinogenic agents |
| 08/05/1997 | US5654326 1H-indole-3-glyoxylamide SPLA2 inhibitors |
| 08/05/1997 | US5654308 Prevent or treat disease due to insufficient choline function |
| 08/05/1997 | US5654306 Piperidine derivative and pharmaceutical composition |
| 08/05/1997 | US5654303 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 08/05/1997 | US5654299 Aryl substituted heterocycles |
| 08/05/1997 | US5654281 Inhibiting the development of tolerance to and/or dependence on an addictive substance |
| 08/05/1997 | US5654279 Tissue destruction in cryosurgery by use of thermal hysteresis |
| 08/05/1997 | US5654277 Inhibiting tumor metastasis in mammals by administering specific tetra- or pentapeptides |
| 08/05/1997 | US5654173 Secreted proteins and polynucleotides encoding them |
| 08/05/1997 | US5653998 With short-chain fatty acid stabilizers for active compounds from the dihydropyridines group |
| 08/05/1997 | US5653984 Extract of periwinkle seed and compositions containing the same |
| 08/05/1997 | CA1339197C A tissue adhesive |
| 08/03/1997 | CA2196392A1 Tetrahydroisoquinoline derivatives |
| 07/31/1997 | WO1997027299A1 Mammalian cx3c chemokine genes |
| 07/31/1997 | WO1997027297A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | WO1997027220A2 Substrates and inhibitors for cysteine protease ich-1 |
| 07/31/1997 | WO1997027216A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | WO1997027199A1 Pyrrolopyrimidines and processes for their preparation |
| 07/31/1997 | WO1997027190A1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them |
| 07/31/1997 | WO1997027185A1 Piperidone tachykinin antagonists |
| 07/31/1997 | WO1997027183A1 Guanidine derivatives |
| 07/31/1997 | WO1997027180A1 Aspartyl protease inhibitors |
| 07/31/1997 | WO1997027177A2 Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 07/31/1997 | WO1997026918A2 Ligand directed enzyme prodrug therapy |
| 07/31/1997 | WO1997026915A1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 07/31/1997 | WO1997026894A1 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution |
| 07/31/1997 | WO1997026878A1 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| 07/31/1997 | WO1997026867A2 Solid instant-release forms of administration and process for producing the same |
| 07/31/1997 | WO1997026862A2 Improved concentrated injection and infusion solutions for intravenous administration |
| 07/31/1997 | DE19604231A1 Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen A pharmaceutical combination preparation, and its use for the treatment of gynecological disorders |
| 07/31/1997 | DE19602757A1 Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung Fixed instant release dosage forms and methods for their preparation |
| 07/31/1997 | CA2244189A1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them |
| 07/31/1997 | CA2243964A1 Solid instant-release forms of administration and processes for their production |
| 07/31/1997 | CA2243497A1 Substrates and inhibitors for cysteine protease ich-1 |